Transgender and gender diverse children might choose to temporarily suppress puberty through the use of prescription medications called pubertal blockers. But deciding to get this treatment is a big step.
Here's what you need to know about the pubertal blocker medication known as gonadotropin-releasing hormone (GnRH) analogues, including the benefits, side effects and long-term effects.
Puberty's physical changes can cause intense distress for many gender-nonconforming adolescents. When taken regularly, GnRH analogues suppress the body's release of sex hormones, including testosterone and estrogen, during puberty. These hormones affect:
- Primary sex characteristics. These are the sexual organs present at birth, including the penis, scrotum and testicles and the uterus, ovaries and vagina.
- Secondary sex characteristics. These are the physical changes in the body that typically appear during puberty. Examples include breast development and growth of facial hair.
In those identified as male at birth, GnRH analogues decrease the growth of facial and body hair, prevent voice deepening, and limit the growth of genitalia.
In those identified as female at birth, treatment limits or stops breast development and delays or stops menstruation.
Gender dysphoria is the feeling of discomfort or distress that might accompany a difference between experienced or expressed gender and sex assigned at birth.
For children who have gender dysphoria, suppressing puberty might:
- Improve mental well-being
- Reduce depression and anxiety
- Improve social interactions and integration with other kids
- Eliminate the need for future surgeries
- Reduce thoughts or actions related to self-harm
However, puberty suppression alone might not ease gender dysphoria.
To begin using pubertal blockers, a child must:
- Show a long-lasting and intense pattern of gender nonconformity or gender dysphoria
- Have gender dysphoria that began or worsened at the start of puberty
- Address any psychological, medical or social problems that could interfere with treatment
- Provide informed consent
Particularly when a child hasn't reached the age of medical consent, parents or other caretakers or guardians must consent to the treatment and support the adolescent through the treatment process.
Use of GnRH analogues doesn't cause permanent changes in an adolescent's body. Instead, it pauses puberty, providing time to determine if a child's gender identity is long lasting. It also gives children and their families time to think about or plan for the psychological, medical, developmental, social and legal issues ahead.
If an adolescent child stops taking GnRH analogues, puberty will resume.
For most children, puberty begins around ages 10 to 11, though some start earlier. The effect of pubertal blockers depends on when a child begins to take the medication. GnRH analogue treatment can begin at the start of puberty to delay secondary sex characteristics. In slightly later stages of puberty, the treatment could be used to stop menstruation or erections or to prevent further development of undesired secondary sex characteristics.
While most children take the medication for a few years, every child is different. After suppressing puberty for a few years, your child might decide to stop hormone therapy or pursue other hormone treatments.
GnRH analogue treatments for children are prescribed, administered and monitored by a pediatric endocrinologist. The medication is typically given as injections, either monthly or every three months, or through an implant placed under the skin of the upper arm. The implant typically needs to be replaced every 12 months.
While taking pubertal blockers, your child will have regular blood tests to monitor the medication's effectiveness. Your child will also be monitored for any side effects.
It's important for your child to stay on schedule with all related medical appointments. Contact your child's doctor if any changes cause you or your child concern.
Possible side effects of GnRH analogue treatment include:
- Injection site swelling
- Weight gain
- Hot flashes
Use of GnRH analogues might also have long-term effects on:
- Bone density
- Future fertility
Children will likely have their height checked every three months. Your child's doctor might recommend yearly bone density and bone age tests.
If children with male genitalia begin using GnRH analogues early in puberty, they might not develop enough penile and scrotal skin for certain gender confirmation genital surgical procedures, such as penile inversion vaginoplasty. Alternative techniques, however, are available.
In addition, delaying puberty beyond one's peers can be stressful. Your child might experience lower self-esteem.
Assessment and counseling by a behavioral health provider can help you and your child as you move through the decision-making process and provide support during therapy. Engaging your child's school teachers and officials also might help ease your child's social adjustment during this process.
After a period of adjusting to pubertal blockers, adolescents might work with their care team to add cross-hormone treatment. This is done to develop masculine or feminine secondary sex characteristics, helping the mind and body look and act like the gender with which your child identifies. Keep in mind that some of these changes aren't reversible or will require surgery to reverse the effects.
GnRH analogues aren't the only medications that can delay puberty. If you're interested in alternative treatments, talk to your child's doctor.
Aug. 16, 2019
- AskMayoExpert. Gender dysphoria/incongruency (child and adolescent); Medical treatment (child and adolescent). Mayo Foundation for Medical Education and Research; 2018.
- Coleman E, et al. Standards of Care for the Health of Transsexual, Transgender and Gender Nonconforming People. 7th version. The World Professional Association for Transgender Health; 2012. http://www.wpath.org. Accessed April 10, 2019.
- Olson-Kennedy J, et al. Management of transgender and gender diverse children and adolescents. https://www.uptodate.com/content/search. April 10, 2019.
- Rafferty J, et al. Ensuring comprehensive care and support for transgender and gender diverse children and adolescents. American Academy of Pediatrics Policy. http://pediatrics.aappublications.org/collection. Accessed April 10, 2019.
- Schechter LS, ed. Medical therapy. In: Surgical Management of the Transgender Patient. Elsevier; 2017. https://www.clinicalkey.com. Accessed April 12, 2019.
- Office of Patient Education. Pubertal blockers for transgender and gender non-conforming youth. Mayo Foundation for Medical Education and Research; 2017.